Dynavax is dedicated to developing and commercializing innovative vaccines that modulate the immune system to prevent disease.

Dynavax Technologies Corporation (Nasdaq: DVAX) is a fully-integrated biopharmaceutical company focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation. Dynavax develops, and commercializes novel vaccines.

They are committed to a rigorous approach to drug development in the field of TLR biology so that they may help physicians and patients address unmet needs. Their vision and work ethic are guided by the collective ideals underpinning their corporate values, and these form the basis of their company culture.